64
Participants
Start Date
November 30, 2017
Primary Completion Date
February 2, 2021
Study Completion Date
February 2, 2021
Capecitabine plus temozolomide VS Capecitabine
"For each cohort of MGMT hypermethylated versus MGMT unmethylated, patients will be randomised (ratio 1:1 for each arm) into preoperative CRT with capecitabine or preoperative CRT with temozolomide plus capecitabine arms.~Chemotherapy during preoperative chemoradiotherapy:~Capecitabine and temozolomide will be administered during radiotherapy with drug holidays (weekend break).~dosage: Capecitabine 825 mg/m2 twice daily, Temozolomide 75 mg/m2/day"
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER